← The SEC Ephemeris: the whole map
Acer Therapeutics Inc. sodium phenylbutyrate
In the graph: all 1 documents (3 pages).
- Application
- NDA 214860
- Ticker
- Acer Therapeutics Inc.
- Product
- sodium phenylbutyrate
- Disease area
- Not yet classified
- Response path
- Not yet classified
- Complete Response Letters
- June 15, 2022
From FDA letters and SEC filings. Not investment or medical advice.